• Home
  • LABORATORIOS RUBIO SA

LABORATORIOS RUBIO SA

About LABORATORIOS RUBIO SA

For more than 50 years, Laboratorios Rubio, a family-owned company, has been recognized for the development, manufacture and marketing of medicines with high therapeutical value for specialists as well as of certain drugs for life-threatening diseases, with long expertise in niche markets. Laboratorios Rubio's determination to meet the health needs of every single patient has led the company to be distinguished as per being pioneer of products targeted to low incidence diseases which affect only to a small number of patients and that require the development of specific pharmaceutical products to treat them.

Within the niche market strategy, Laboratorios Rubió has been pioneer and innovative company among the Spanish pharmaceutical companies focus on, but not limited, to therapeutical areas such as: CNS, Anti-rheumatic, Nephrology, Urology, CV, GI, Psychiatry, etc. It is worth highlighting the success of RUBIFEN® & RUBIFEN® RETARD (Methylphenidate), RESINCALCIO® (Calcium Polystyrene Sulphonate), RESINSODIO® (Sodium Polystyrene Sulphonate), RESINCOLESTIRAMINA® (Cholestyramine), RUBI-DIET® NEFRO & RUBI-DIET® NEFRO PLUS (nutrition in CKD) and MELATONIN.

For more information, please visit us on www.laboratoriosrubio.com

Read more Show less
Certifications
  • CE
  • FDA
    FDA
  • GMP
  • ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2015
    On CPhI since
  • 4
    Certificates
  • 100 - 249
    Employees
Contact info
Show contact info Hide contact info
Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy
9-11 November 2021
View Exhibitor Profile

Products from LABORATORIOS RUBIO SA

  • Resincalcio

    Product Resincalcio

    RESINCALCIO® is powder for oral suspension. Treatment and prevention of hyperkalaemia (hiperpotassemia). Polystyrene sulfonate is a cation exchange resin whose action takes place primarily in the colon: when in contact with intestinal contents occurs ion exchange whereby each calcium cation is exchanged for two potassium cations. Since calcium polystyrene sulfonate is not absorbed, there is no systemic toxicity. Packs: 15 g x 26 sachets/ 5 g x 100 sachets/  400 g multi-dose plastic bottle with a measuring spoon that holds approx. 5 g
  • Calcium polystyrene sulfonate

    Product Calcium polystyrene sulfonate

    Treatment and prevention of hyperkalaemia (hiperpotassemia). Polystyrene sulfonate is a cation exchange resin whose action takes place primarily in the colon: when in contact with intestinal contents occurs ion exchange whereby each calcium cation is exchanged for two potassium cations. Since calcium polystyrene sulfonate is not absorbed, there is no systemic toxicity. Packs: 15 g x 26 sachets/ 5 g x 100 sachets/  400 g multi-dose plastic bottle with a measuring spoon that holds approx. 5 g

  • Cholestyramine Resin

    Product Cholestyramine Resin

    Resincolestiramina + Stains achieve a significant reduction in LDL-c.brhrbrTreatment and reduction of blood cholesterol levels and treatment of pruritus by bile stasis.
    Treatment of Intractable infant diarrhea and pseudomembranous colitis.
  • Melatonin

    Product Melatonin

    Melatonin 2mg prolonged-release tablets
    Monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.
    ·       Dose: 2 mg once daily, 1-2 hours before bedtime and after food. This dosage may be continued for up to thirteen weeks.
    ·       Modified-release melatonin causes the blood concentration over time to more closely mimic a naturally occurring melatonin profile.


  • Methylphenidate hydrochloride 10 mg

    Product Methylphenidate hydrochloride 10 mg

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
  • Methylphenidate Hydrochloride 20mg

    Product Methylphenidate Hydrochloride 20mg

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
  • Methylphenidate hydrochloride 5mg

    Product Methylphenidate hydrochloride 5mg

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
  • Resincolestiramina

    Product Resincolestiramina

    Resincolestiramina + Stains achieve a significant reduction in LDL-c.brhrbrTreatment and reduction of blood cholesterol levels and treatment of pruritus by bile stasis.
    Treatment of Intractable infant diarrhea and pseudomembranous colitis.
  • Resinsodio

    Product Resinsodio

    Sodium polystyrene sulfonate is a cation exchange resin whose action takes place primarily in the colon: when in contact with intestinal contents occurs ion exchange whereby each sodium cation is exchanged for one potassium cations. Since sodium polystyrene sulfonate is not absorbed, there is no systemic toxicity. Treatment and prevention of Hyperkalaemia. Pack: 400 g multi-dose plastic bottle with a measuring spoon that holds approx. 5 g of powder.                                   
  • Rubi-diet Nefro

    Product Rubi-diet Nefro

    Nutritionally complete, high-caloric and moderate protein formula with fibre intended for the dietary management of chronic kidney disease (CKD) undernourished patients in pre-dialysis or those at risk of malnutrition.
    Main presentation: 36 sachets of 90g each

    Per each sachet of 90g:
    Energy: 400 kcal
    Proteins: 10g
    Fats: 14g
    Carbohydrates: 58g
    Prebiotic fibre (native chicory inulin): 4g

  • Rubifen 10mg

    Product Rubifen 10mg

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
  • Rubifen 20mg

    Product Rubifen 20mg

    Mind Stimulant of Central Nervous SystembrhrbrTreatment for Attention deficit disorder with hyperactivity (ADHD) in children over 6 years old and adolescents.
show all products

LABORATORIOS RUBIO SA Resources